Dexilant and Seebri drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Dexilant (dexlansoprazole) and Seebri (glycopyrrolate). Common drug interactions include blood pressure systolic increased among females and asthma among males.

The phase IV clinical study analyzes what interactions people have when they take Dexilant and Seebri. It is created by eHealthMe based on reports of 99 people who take the same drugs from the FDA, and is updated regularly.

What is Dexilant?

Dexilant has active ingredients of dexlansoprazole. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 57,103 Dexilant users. Check the latest studies of Dexilant.

What is Seebri?

Seebri has active ingredients of glycopyrrolate. eHealthMe is studying from 2,618 Seebri users. Check the latest studies of Seebri.

On Jul, 13, 2026

99 people who take Dexilant and Seebri together, and have interactions are studied.

What are the common drug interactions of Dexilant and Seebri, by gender? *:

female:

Blood pressure systolic increased
Dyspnoea (difficult or laboured respiration)
Pneumonia
Asthma
Cough
Drug ineffective
Forced expiratory volume decreased (decreased lung expired air volume)
Lower respiratory tract infection
Obstructive airways disorder (a progressive disease that makes it hard to breathe)
Pulmonary thrombosis (scarring in the lungs)

male:

Asthma
Dyspnoea (difficult or laboured respiration)
Respiratory disorder (respiratory disease)
Thrombocytopenia (decrease of platelets in blood)
Blood immunoglobulin e increased
Dyspnoea at rest (difficult or laboured breathing during rest)
Dyspnoea exertional (breathlessness or shortness of breath)
Malaise (a feeling of general discomfort or uneasiness)
Micturition urgency (urgency to pass the urine)
Mobility decreased (ability to move is reduced)

What are the common drug interactions of Dexilant and Seebri, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Thrombocytopenia (decrease of platelets in blood)
Cerebral haemorrhage (bleeding within the brain)
Ruptured cerebral aneurysm (bleeding from brain)
Subarachnoid haemorrhage (blood leaks into the space between two membranes that surround the brain)

60+:

Dyspnoea (difficult or laboured respiration)
Asthma
Respiration (transport of oxygen from the outside air to the cells within tissues)
Total lung capacity increased
Dyspnoea exertional (breathlessness or shortness of breath)
Malaise (a feeling of general discomfort or uneasiness)
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Peak expiratory flow rate decreased
Abdominal pain
Blood pressure decreased

What are the existing conditions these people have? *

Asthma: 86 people, 86.87%
High Blood Cholesterol: 17 people, 17.17%

* Approximation only. Some reports may have incomplete information.

Do you take Dexilant and Seebri?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously